Aigen Investment Management LP Acquires Shares of 36,641 Envista Holdings Co. (NYSE:NVST)

Aigen Investment Management LP acquired a new stake in Envista Holdings Co. (NYSE:NVSTFree Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 36,641 shares of the company’s stock, valued at approximately $882,000.

Several other hedge funds also recently added to or reduced their stakes in NVST. Retirement Systems of Alabama increased its position in shares of Envista by 2.0% during the fourth quarter. Retirement Systems of Alabama now owns 504,572 shares of the company’s stock worth $12,140,000 after acquiring an additional 10,120 shares during the last quarter. Foundry Partners LLC purchased a new stake in shares of Envista during the fourth quarter worth about $3,571,000. Raymond James & Associates increased its position in shares of Envista by 820.6% during the fourth quarter. Raymond James & Associates now owns 408,218 shares of the company’s stock worth $9,822,000 after acquiring an additional 363,875 shares during the last quarter. Dynamic Technology Lab Private Ltd increased its position in shares of Envista by 144.1% during the fourth quarter. Dynamic Technology Lab Private Ltd now owns 73,689 shares of the company’s stock worth $1,773,000 after acquiring an additional 43,500 shares during the last quarter. Finally, River Road Asset Management LLC purchased a new stake in shares of Envista during the fourth quarter worth about $54,931,000.

Analyst Ratings Changes

NVST has been the subject of a number of research reports. Leerink Partnrs reiterated an “underperform” rating on shares of Envista in a research note on Monday, February 26th. JPMorgan Chase & Co. decreased their price target on Envista from $29.00 to $23.00 and set an “overweight” rating for the company in a research note on Thursday, May 2nd. The Goldman Sachs Group decreased their price target on Envista from $20.00 to $17.50 and set a “sell” rating for the company in a research note on Friday, May 3rd. TheStreet downgraded Envista from a “c” rating to a “d+” rating in a research note on Wednesday, February 7th. Finally, Jefferies Financial Group downgraded Envista from a “buy” rating to a “hold” rating and decreased their target price for the company from $30.00 to $23.00 in a research note on Friday, February 9th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $25.86.

View Our Latest Research Report on Envista

Envista Stock Up 1.6 %

NYSE:NVST traded up $0.30 during midday trading on Wednesday, hitting $18.65. 513,976 shares of the stock were exchanged, compared to its average volume of 2,249,789. Envista Holdings Co. has a one year low of $17.90 and a one year high of $36.14. The business has a 50-day moving average price of $20.11 and a two-hundred day moving average price of $22.09. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.27 and a quick ratio of 1.93.

Envista (NYSE:NVSTGet Free Report) last announced its earnings results on Wednesday, May 1st. The company reported $0.26 EPS for the quarter, missing the consensus estimate of $0.31 by ($0.05). The firm had revenue of $623.60 million for the quarter, compared to the consensus estimate of $634.85 million. Envista had a positive return on equity of 5.84% and a negative net margin of 4.70%. Envista’s revenue for the quarter was down .6% on a year-over-year basis. During the same period in the previous year, the firm earned $0.38 EPS. On average, research analysts expect that Envista Holdings Co. will post 1.26 EPS for the current year.

Envista Profile

(Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

Featured Articles

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.